Dianthus Therapeutics, Inc. /DE/ - Common Stock (DNTH)

CUSIP: 252828108

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 6 signals
Share change
+3,614,619
SEC-reported price per share
$25.88
Number of holders
74
Value change
+$87,583,327
Number of buys
46
Number of sells
45
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
56,039,094

Security key

252828108

Report period

Q2 2024

Institutions

74

Top holders

10

Ownership snapshot

Top reported holders of DNTH - Dianthus Therapeutics, Inc. /DE/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Third Rock Ventures IV, L.P.
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
23 May 2024
3/4/5 13F Highest disclosed value: $124,831,350 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $124.83M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
Third Rock Ventures IV, L.P. $36.7M
FMR LLC $124.83M
Bain Capital Life Sciences Invest... $89.76M
Fairmount Funds Management LLC $82.89M
Avidity Partners Management LP $81.53M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Third Rock Ventures IV, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$36,698,448
3,058,204 shares
— 07 Feb 2023
FMR LLC
13F
Company
13F
—
denominator unverified
$124,831,350
4,161,045 shares
— 31 Mar 2024
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
—
denominator unverified
$89,760,840
2,992,028 shares
— 31 Mar 2024
Fairmount Funds Management LLC
13F
Company
13F
—
denominator unverified
$82,885,110
2,762,837 shares
— 31 Mar 2024
Avidity Partners Management LP
13F
Company
13F
—
denominator unverified
$81,526,620
2,717,554 shares
— 31 Mar 2024
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$69,990,000
2,333,000 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
74
Shares
29,702,499
Rows available
74
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
75
Q2 2024 holders
74
Holder diff
-1
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .